Abstract
ATP increases cAMP formation in bovine chromaffin cells, EC(50) = 7.1 x 10(-6) M. NPY, EC(50) = 4.1 x 10(-8) M, increases the efficacy of ATP (1.5-2 fold). Inclusion of the selective Y1 receptor antagonist 1229U91 produced a decrease in NPY potency (EC(50) = 2.7 x 10(-7) M). PTX pretreatment did not abolish either the effect of ATP nor the enhancement by NPY. NPY could also enhance the ability of angiotensin and bradykinin to increase cAMP formation. The selective phospholipase C inhibitor, U73122, and the selective protein kinase C inhibitors, bisindolylmaleimide I and RO-31-8425, were effective inhibitors of the enhancing effect of NPY.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenosine Triphosphate / metabolism*
-
Animals
-
Cattle
-
Cells, Cultured
-
Chromaffin Cells / metabolism*
-
Cyclic AMP / metabolism*
-
Dose-Response Relationship, Drug
-
Enzyme Inhibitors / pharmacology
-
Estrenes / pharmacology
-
Indoles / pharmacology
-
Maleimides / pharmacology
-
Neuropeptide Y / antagonists & inhibitors
-
Neuropeptide Y / metabolism*
-
Peptides, Cyclic / pharmacology
-
Phosphodiesterase Inhibitors / pharmacology
-
Protein Kinase C / antagonists & inhibitors
-
Pyrrolidinones / pharmacology
-
Type C Phospholipases / antagonists & inhibitors
-
Virulence Factors, Bordetella / pharmacology
Substances
-
1229U91
-
Enzyme Inhibitors
-
Estrenes
-
Indoles
-
Maleimides
-
Neuropeptide Y
-
Peptides, Cyclic
-
Phosphodiesterase Inhibitors
-
Pyrrolidinones
-
Virulence Factors, Bordetella
-
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
-
Ro 31-8425
-
Adenosine Triphosphate
-
Cyclic AMP
-
Protein Kinase C
-
Type C Phospholipases
-
bisindolylmaleimide I